<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ca">
	<id>http://traba.org:8080/index.php?action=history&amp;feed=atom&amp;title=Hipertrigliceridemia</id>
	<title>Hipertrigliceridemia - Historial de revisió</title>
	<link rel="self" type="application/atom+xml" href="http://traba.org:8080/index.php?action=history&amp;feed=atom&amp;title=Hipertrigliceridemia"/>
	<link rel="alternate" type="text/html" href="http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;action=history"/>
	<updated>2026-04-16T00:58:29Z</updated>
	<subtitle>Historial de revisió per a aquesta pàgina del wiki</subtitle>
	<generator>MediaWiki 1.39.13</generator>
	<entry>
		<id>http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9723&amp;oldid=prev</id>
		<title>83.247.136.48: /* Epidemiologia */</title>
		<link rel="alternate" type="text/html" href="http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9723&amp;oldid=prev"/>
		<updated>2007-08-30T07:07:56Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Epidemiologia&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:07, 30 ago 2007&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3&quot;&gt;Línia 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=Epidemiologia=&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=Epidemiologia=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;*La afavoreixen la DM mal controlada, el sedentarisme, l'alcoholisme, tabaquisme i la obesitat.&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hi ha dues causes genètiques que presenten una hipertrigliceridèmia extremadament alta: el dèficit de lipoprotein-lipasa i el de l'apolipoproteina C-II.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hi ha dues causes genètiques que presenten una hipertrigliceridèmia extremadament alta: el dèficit de lipoprotein-lipasa i el de l'apolipoproteina C-II.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hipotiroïdisme.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hipotiroïdisme.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>83.247.136.48</name></author>
	</entry>
	<entry>
		<id>http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9722&amp;oldid=prev</id>
		<title>83.247.136.48: /* Epidemiologia */</title>
		<link rel="alternate" type="text/html" href="http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9722&amp;oldid=prev"/>
		<updated>2007-08-30T07:07:32Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Epidemiologia&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:07, 30 ago 2007&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l3&quot;&gt;Línia 3:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 3:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=Epidemiologia=&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;=Epidemiologia=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br/&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;*La afavoreixen la DM mal controlada, el sedentarisme, l'alcoholisme, tabaquisme i la obesitat.&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-added&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hi ha dues causes genètiques que presenten una hipertrigliceridèmia extremadament alta: el dèficit de lipoprotein-lipasa i el de l'apolipoproteina C-II.  &lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hi ha dues causes genètiques que presenten una hipertrigliceridèmia extremadament alta: el dèficit de lipoprotein-lipasa i el de l'apolipoproteina C-II.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hipotiroïdisme.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;*Hipotiroïdisme.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>83.247.136.48</name></author>
	</entry>
	<entry>
		<id>http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9721&amp;oldid=prev</id>
		<title>62.57.42.243: Pàgina nova, amb el contingut: «Categoria:Pasando visita  =Epidemiologia=  *La afavoreixen la DM mal controlada, el sedentarisme, l'alcoholisme, tabaquisme i la obesitat. *Hi ha dues causes...».</title>
		<link rel="alternate" type="text/html" href="http://traba.org:8080/index.php?title=Hipertrigliceridemia&amp;diff=9721&amp;oldid=prev"/>
		<updated>2007-08-29T17:12:21Z</updated>

		<summary type="html">&lt;p&gt;Pàgina nova, amb el contingut: «&lt;a href=&quot;/Categoria:Pasando_visita&quot; title=&quot;Categoria:Pasando visita&quot;&gt;Categoria:Pasando visita&lt;/a&gt;  =Epidemiologia=  *La afavoreixen la DM mal controlada, el sedentarisme, l&amp;#039;alcoholisme, tabaquisme i la obesitat. *Hi ha dues causes...».&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pàgina nova&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Categoria:Pasando visita]]&lt;br /&gt;
&lt;br /&gt;
=Epidemiologia=&lt;br /&gt;
&lt;br /&gt;
*La afavoreixen la DM mal controlada, el sedentarisme, l'alcoholisme, tabaquisme i la obesitat.&lt;br /&gt;
*Hi ha dues causes genètiques que presenten una hipertrigliceridèmia extremadament alta: el dèficit de lipoprotein-lipasa i el de l'apolipoproteina C-II. &lt;br /&gt;
*Hipotiroïdisme.&lt;br /&gt;
*Síndrome nefròtic. &lt;br /&gt;
*Fàrmacs: tiazides, beta-bloquejants, THS, anticonceptius orals, tamoxifè, corticoides, isotretionina, antiretrovirals.&lt;br /&gt;
*Alcoholisme i dietes riques en carbohidrats.&lt;br /&gt;
*Pancreatitis.&lt;br /&gt;
*Embaraç.&lt;br /&gt;
&lt;br /&gt;
=Clínica=&lt;br /&gt;
&lt;br /&gt;
En general, asimptomàtica. &lt;br /&gt;
Pot ser causa de pancreatitis aguda, sobretot si els nivells superen els 5000 mg/dl. &lt;br /&gt;
Xantomes (benignes).&lt;br /&gt;
Hepato o esplenomegàlia és més rar.&lt;br /&gt;
''Lipemia retinalis'': fons d'ull pal·lid, quan els nivells superen els 4000 mg/dl.&lt;br /&gt;
Símptomes neurològics: depressió, pèrdua de memòria o demència.&lt;br /&gt;
&lt;br /&gt;
=Diagnòstic=&lt;br /&gt;
&lt;br /&gt;
==Deficició==&lt;br /&gt;
&lt;br /&gt;
Es defineix com a uns TG superiors a 200 mg/dl. Hi ha varis tipus.&lt;br /&gt;
&lt;br /&gt;
==Exploracions complementàries==&lt;br /&gt;
&lt;br /&gt;
Perfil lipídic amb 0-12 hores de dejuni. Descartar hipotiroïdisme i diabetis.&lt;br /&gt;
&lt;br /&gt;
=Maneig=&lt;br /&gt;
&lt;br /&gt;
==Tractament==&lt;br /&gt;
&lt;br /&gt;
===Objectius===&lt;br /&gt;
&lt;br /&gt;
Pendent de veure els objectius de tractament.&lt;br /&gt;
&lt;br /&gt;
===Tractament===&lt;br /&gt;
&lt;br /&gt;
Tractament de la causa primària si es troba.&lt;br /&gt;
Dieta.&lt;br /&gt;
Exercici.&lt;br /&gt;
Gemfibrozilo 600 mg cada 12h 30 minuts abans dels menjars.&lt;br /&gt;
&lt;br /&gt;
==Criteris de derivació==&lt;br /&gt;
&lt;br /&gt;
Si no s'assoleixen els objectius terapèutics.&lt;br /&gt;
&lt;br /&gt;
=Pronòstic=&lt;br /&gt;
&lt;br /&gt;
És un factor de risc cardiovascular, excepte si és per causa del dèficit de les proteïnes anteriorment mencionades. Sobretot si s'acompanya de un cHLD baix i/o cLDL alt.&lt;/div&gt;</summary>
		<author><name>62.57.42.243</name></author>
	</entry>
</feed>